Document Documentand Entity Information [Abstract] Document - Document and Entity Information [Abstract] Document - Document and Entity Information [Abstract] Document - Document and Entity Information [Abstract] Document Type Document Type Document Type Amendment Flag Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS ASSETS Assets Current [Abstract] Current Assets Current Assets Cash and Cash Equivalents At Carrying Value Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Prepaid Expense and Other Assets Current Prepaid expenses and other current assets Prepaid expenses and other current assets Assets Current Total current assets Total current assets Property Plant and Equipment Net Fixed assets, net Fixed assets, net Intangible Assets Net Excluding Goodwill Capitalized patent and patent application costs Other assets, net Assets Total assets Total assets Liabilities and Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current [Abstract] Current Liabilities Current Liabilities Accounts Payable Current Accounts payable Accounts payable Accrued Liabilities Current Accrued expenses Accrued expenses Total Liabilities Current Total current liabilities Total current liabilities Stockholders Equity [Abstract] Stockholders' Equity Stockholders' Equity Preferred Stock Value Undesignated Preferred Stock, $.001 par value, 5,000,000 shares authorized, none issued and outstanding Undesignated Preferred Stock, $.001 par value, 5,000,000 shares authorized, none issued and outstanding Common Stock Value Common Stock, $.001 par value, 75,000,000 shares authorized, 17,228,707 and 12,470,694 shares issued, respectively and 17,116,357 and 12,358,344 shares outstanding, respectively Common Stock, $.001 par value, 75,000,000 shares authorized, 14,946,339 and 12,470,694 shares issued, respectively and 14,833,989 and 12,358,344 shares outstanding, respectively Additional Paid In Capital Additional paid-in capital Additional paid-in capital Treasury Stock Value Cost of treasury stock, 112,350 shares Cost of treasury stock, 112,350 shares Development Stage Enterprise Deficit Accumulated During Development Stage Deficit accumulated during development stage Deficit accumulated during the development stage Deficit accumulated during the development stage Stockholders Equity Total stockholders' equity Total stockholders' equity Beginning Balance Ending Balance Liabilities and Stockholders Equity Total liabilities and stockholders' equity Total liabilities and stockholders' equity Preferred Stock Par Or Stated Value Per Share Preferred Stock, par value Preferred Stock, par value Preferred Stock Shares Authorized Preferred Stock, shares authorized Preferred Stock, shares authorized Preferred Stock Shares Issued Preferred Stock, issued Preferred Stock, issued Preferred Stock Shares Outstanding Preferred Stock, outstanding Preferred Stock, outstanding Common Stock Par Or Stated Value Per Share Common Stock, par value Common Stock, par value Common Stock Shares Authorized Common Stock, shares authorized Common Stock, shares authorized Common Stock Shares Issued Common Stock, shares issued Common Stock, shares issued Common Stock Shares Outstanding Common Stock, shares outstanding Common Stock, shares outstanding Treasury Stock Shares Treasury stock, shares Treasury stock, shares Income Statement [Abstract] Income Statement [Abstract] Income Statement [Abstract] Revenues [Abstract] Revenues Revenues Licenses Revenue Licensing fees Licensing fees Royalty Revenue Product royalties Product royalties Revenue From Grants Research and development grants Research and development grants Investment Income Interest Interest income Interest income Gains Losses On Sales Of Assets Gain on disposal of fixed assets Gain on disposal of fixed assets Gain on disposal of fixed assets Other Nonoperating Income Other Income Other Income Revenues Total revenues and other income Total revenues and other income Costs and Expenses [Abstract] Expenses Expenses Research and Development Expense Research and development Research and development General and Administrative Expense General and administrative General and administrative Other Cost and Expense Operating Interest expense and amortization of intangibles Interest expense and amortization of intangibles Costs and Expenses Total expenses Total expenses Income Loss From Continuing Operations Loss from continuing operations Loss from continuing operations Income Loss From Discontinued Operations Net Of Tax Loss from discontinued operations Loss from discontinued operations Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Gain on disposal of discontinued operation Gain on disposal of discontinued operations Gain on disposal of discontinued operations Income Loss Before Extraordinary Items and Cumulative Effect Of Change In Accounting Principle Net loss before cumulative effect of change in accounting principle Net loss before cumulative effect of change in accounting principle New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Income Cumulative effect of change in accounting principle Cumulative effect of change in accounting principle Net Income Loss Net loss Net loss Net Loss Net loss Earnings Per Share Basic and Diluted Basic and diluted loss per share Loss per share - basic and diluted: Weighted Average Number Of Shares Outstanding [Abstract] Weighted average shares used in loss per share calculation: Weighted average shares used in loss per share calculation: Weighted Average Number Of Shares Outstanding Basic Basic Basic Weighted Average Number Of Diluted Shares Outstanding Diluted Diluted Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement Equity Components [Axis] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid In Capital [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Treasury Stock [Member] Accumulated Deficit During Development Stage [Member] Deficit Accumulated During the Development Stage [Member] Statement Class Of Stock [Axis] Class of Stock [Axis] Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Class of Stock [Domain] Issuance During Period One [Member] Issuance During Period 1st [Member] Issuance During Period 1st [Member] Issuance During Period Two [Member] Issuance During Period 2nd [Member] Issuance During Period 2nd [Member] Issuance During Period Three [Member] Issuance During Period 3rd [Member] Issuance During Period Four [Member] Issuance During Period 4th [Member] Shares Issued Beginning Balance (in shares) Beginning Balance (in shares) Ending Balance (in shares) Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock based option compensation Stock based option compensation Stock Issued During Period Shares New Issues Issuance of common stock (in shares) Issuance of common stock, share Stock Issued During Period Value New Issues Issuance of common stock Issuance of common stock Stock Issued During Period Shares Stock Options Exercised Exercise of stock options to purchase common stock for cash ($1.33 to $10.88 per share)(in shares) Exercise of stock option to purchase common stock for cash @ $4.80 per share (in shares) Stock Issued During Period Value Stock Options Exercised Exercise of stock options to purchase common stock for cash ($1.33 to $10.88 per share) Exercise of stock option to purchase common stock for cash @ $4.80 per share Stock Issued During Period Shares Stock Warrants Exercised Exercise of 121,079 Series B Warrants to purchase common stock for cash @ $2.49 per share (in shares) Exercise of 3,675 Series B Warrants to purchase common stock for cash @ $2.49 per share (in shares) Number of shares issued during the period as a result of the exercise of warrants. Stock Issued During Period Value Stock Warrants Exercised Exercise of 3,675 Series B Warrants to purchase common stock for cash @ $2.49 per share Exercise of 3,675 Series B Warrants to purchase common stock for cash @ $2.49 per share Value stock issued during the period as a result of the exercise of warrants. Stock Option [Member] Stock Option [Member] Series B Warrant [Member] Series B Warrants [Member] Series B Warrant Range [Axis] Range [Axis] Range [Domain] Range [Domain] Maximum [Member] Minimum [Member] Equity Issuance Per Share Amount Common stock, price per share Common stock, price per share Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Issuance of common stock, offering costs Issuance of common stock, offering costs Common Stock Option Shares Common Stock Option Shares Issuance of common stock offered cashless exercise stock option. Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Net Cash Provided By Used In Operating Activities [Abstract] Cash Flows from Operating Activities Cash Flows from Operating Activities Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Amortization Of Financing Costs Noncash financing costs Noncash financing costs Inventory Write Down Noncash inventory impairment Noncash inventory impairment Impairment Of Intangible Assets Excluding Goodwill Noncash patent impairment Noncash patent impairment Other Noncash Income Noncash other income Noncash other income Gains Losses On Extinguishment Of Debt Noncash decrease in accounts payable Noncash decrease in accounts payable Depreciation and Amortization Depreciation and amortization Depreciation and amortization Share Based Compensation Noncash stock-based compensation Noncash stock-based compensation Other Noncash Income Expense Common stock issued for agreement not to compete Common stock issued for agreement not to compete Issuance Of Stock and Warrants For Services Or Claims Series B Preferred Stock issued for consulting services Series B Preferred Stock issued for consulting services Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities (net effects of purchase of businesses in 1988 and 1994): Changes in operating assets and liabilities (net effects of purchase of businesses in 1988 and 1994): Increase Decrease In Receivables Increase in receivables Increase in receivables Increase Decrease In Inventories Increase in inventory Increase in inventory Increase Decrease In Prepaid Deferred Expense and Other Assets (Increase) decrease in prepaid expenses and other current assets (Increase) decrease in prepaid expenses and other current assets Increase Decrease In Accounts Payable and Accrued Liabilities Increase (decrease) in accounts payable and accrued expenses Increase (decrease) in accounts payable and accrued expenses Net Cash Provided By Used In Operating Activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided By Used In Investing Activities [Abstract] Cash Flows from Investing Activities Cash Flows from Investing Activities Payments To Acquire Marketable Securities Change in trading marketable securities Change in trading marketable securities Payments To Acquire Property Plant and Equipment Capital expenditures Capital expenditures Payments To Acquire Intangible Assets Capitalization Of Patents and Patent Applications Capitalization of patents and patent applications Proceeds From Sale Of Property Plant and Equipment Proceeds from sale of PP&E Proceeds from sale of PP&E Cash Acquired From Acquisition Cash acquired in purchase of FTI Cash acquired in purchase of FTI Proceeds From Divestiture Of Interest In Consolidated Subsidiaries 1990 phase-out period Proceeds from sale of subsidiary, less $12,345 for operating losses during 1990 phase-out period Proceeds From Divestiture Of Businesses Net Of Cash Divested Proceeds from sale of the assets of FTI Proceeds from sale of the assets of FTI Payments For Proceeds From Other Investing Activities Increase in net assets held for disposal Increase in net assets held for disposal Net Cash Provided By Used In Investing Activities Net cash used in investing activities Net cash used in investing activities Net Cash Provided By Used In Financing Activities [Abstract] Cash Flows from Financing Activities Cash Flows from Financing Activities Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock, net of offering costs Proceeds from issuance of common stock, net of offering costs Proceeds From Stock Options Exercised Exercise of stock options & warrants Exercise of stock options & warrants Proceeds From Contributed Capital Proceeds from a shareholder transaction Proceeds from a shareholder transaction Proceeds From Issuance Of Preferred Stock and Preference Stock Proceeds from issuance of preferred stock Proceeds from issuance of preferred stock Payments For Repurchase Of Common Stock Purchase of treasury stock Purchase of treasury stock Proceeds From Notes Payable Proceeds from issuance of notes payable Proceeds from issuance of notes payable Repayments Of Notes Payable Principal payments on notes payable Principal payments on notes payable Net Cash Provided By Used In Financing Activities Net cash provided by financing activities Net cash provided by financing activities Cash and Cash Equivalents Period Increase Decrease Net increase (decrease) in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Operating Losses During Phase Out Period From Divestiture Of Interest In Consolidated Subsidiaries Proceeds from sale of subsidiary, operating losses during 1990 phase-out period Proceeds from sale of subsidiary, operating losses during 1990 phase-out period Operating Losses During Phase-out Period From Divestiture of Interest in Consolidated Subsidiaries Organization, Operations and Liquidity [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization Consolidation and Presentation Of Financial Statements Disclosure [Text Block] Organization, Operations and Liquidity Organization, Operations and Liquidity Patents and Patent Applications [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Disclosure [Text Block] Patents and Patent Applications Patents and Patent Applications Accrued Expenses [Abstract] Accrued Expenses [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Accrued Expenses Loss Per Share [Abstract] Loss Per Share [Abstract] Earnings Per Share [Text Block] Loss Per Share Loss Per Share Commitments and Contingencies [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Subsequent Events Schedule Of Product Information Table [Text Block] Product Development Pipeline Product Development Pipeline Schedule Of Accrued Liabilities Table [Text Block] Accrued Expenses Accrued Expenses Schedule Of Earnings Per Share Basic and Diluted Table [Text Block] Calculation of Loss Per Share Calculation of Loss Per Share Disclosure Product Development Pipeline [Abstract] Disclosure - Product Development Pipeline [Abstract] Disclosure - Product Development Pipeline [Abstract] Disclosure - Product Development Pipeline [Abstract] Schedule Of Product Information [Table] Schedule of Product Information [Table] Schedule of Product Information [Table] Product Or Service [Axis] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Products and Services [Domain] Androxal [Member] Androxal [Member] Androxal [Member] Proellex [Member] Proellex [Member] Proellex [Member] Products Or Services Secondary Categorization [Axis] Products or Services Secondary Categorization [Axis] Products or Services Secondary Categorization [Axis] Products or Services Secondary Categorization [Axis] Products Or Services Name Secondary Categorization [Domain] Products or Services Name Secondary Categorization [Domain] Products or Services Name Secondary Categorization [Domain] Products or Services Name Secondary Categorization [Domain] Secondary Hypogonadism [Member] Secondary Hypogonadism [Member] Secondary Hypogonadism [Member] Uterine Fibroids [Member] Uterine Fibroids [Member] Uterine Fibroids [Member] Endometriosis [Member] Endometriosis [Member] Endometriosis [Member] Product Information [Line Items] Product Information [Line Items] Product Information [Line Items] Product Status Status Status Product Status Product Next Expected Milestone Next Expected Milestone(s) Next Expected Milestone(s) Product Next Expected Milestone Disclosure Organization Operations and Liquidity Additional Information [Abstract] Disclosure - Organization, Operations and Liquidity - Additional Information [Abstract] Disclosure - Organization, Operations and Liquidity - Additional Information [Abstract] Disclosure - Organization, Operations and Liquidity - Additional Information [Abstract] Period One [Member] One year [Member] Period 1 [Member] Period Two [Member] Six months [Member] Period 2 [Member] Subsidiary, Sale Of Stock [Axis] Subsidiary, Sale of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] Private Placement [Member] Public Offering Net Proceeds Issuance of stock net of offering costs Issuance of stock net of offering costs Public offering, net proceeds Number Of Subjects Required For Registration Number of subjects required for registration Number of subjects required for registration Number of Subjects Required for Registration Number Of Subjects In Study Number of subjects in open label safety study Number of subjects in open label safety study Number of Subjects in Study Proceeds From Issuance Of Private Placement Proceeds from Issuance of Private Placement Accounts Payable and Accrued Liabilities Current Accounts payable and accrued expenses Accounts payable and accrued expenses Disclosure Patents and Patent Applications Additional Information [Abstract] Disclosure - Patents and Patent Applications - Additional Information [Abstract] Disclosure - Patents and Patent Applications - Additional Information [Abstract] Disclosure - Patents and Patent Applications - Additional Information [Abstract] Schedule Of Finite Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Disclosure Accrued Expenses [Abstract] Disclosure - Accrued Expenses [Abstract] Disclosure - Accrued Expenses [Abstract] Disclosure - Accrued Expenses [Abstract] Schedule Of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule Of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Accrued Patent Expense Current Patent costs Patent costs Accrued Patent Expense, Current Accrued Research and Development Expense Current Research and development costs Research and development costs Accrued Research and Development Expense, Current Accrued Personnel Expense Current Personnel related costs Personnel related costs Accrued Personnel Expense Current Other Accrued Liabilities Current Other Other Disclosure Calculation Of Loss Per Share [Abstract] Disclosure - Calculation of Loss Per Share [Abstract] Disclosure - Calculation of Loss Per Share [Abstract] Disclosure - Calculation of Loss Per Share [Abstract] Earnings Per Share Disclosure [Table] Earnings Per Share Disclosure [Table] Earnings Per Share Disclosure [Table] Earnings Per Share Disclosure [Table] Earnings Per Share Disclosure [Line Items] Earnings Per Share Disclosure [Line Items] Earnings Per Share Disclosure [Line Items] Earnings Per Share Disclosure [Line Items] Weighted Average Number Of Share Outstanding Basic and Diluted Average common shares outstanding Average common shares outstanding Disclosure Loss Per Share Additional Information [Abstract] Disclosure - Loss Per Share - Additional Information [Abstract] Disclosure - Loss Per Share - Additional Information [Abstract] Disclosure - Loss Per Share - Additional Information [Abstract] Series Warrant [Member] Series A Warrants [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Anti-dilutive shares of common stock excluded from computation of earning per share Anti-dilutive shares of common stock excluded from computation of earning per share